Tuesday, December 20, 2022

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM

Among patients in a large Israeli health care system who had received at least one dose of the BNT162b2 mRNA vaccine, the estimated incidence of myocarditis was 2.13 cases per 100,000 persons; the highest incidence was among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate in severity.

No comments:

Post a Comment